Search

Current filters:



Use filters to refine the search results.

Results 11-20 of 38 (Search time: 0.014 seconds).
Item hits:
PreviewIssue dateOnline publication dateTitleAuthor(s)
pathogenic_lipidbinding_antip-20220902174134868.pdf.jpg202112-Sep-2022Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19Hollerbach, Anne; Müller-Calleja, Nadine; Pedrosa, Denise; Canisius, Antje; Sprinzl, Martin F.; Falter, Tanja; Rossmann, Heidi; Bodenstein, Marc; Werner, Christian; Sagoschen, Ingo; Münzel, Thomas; Schreiner, Oliver; Sivanathan, Visvakanth; Reuter, Michael; Niermann, Johannes; Galle, Peter R.; Teyton, Luc; Ruf, Wolfram; Lackner, Karl J.
emerging_immunotherapy_for_hc-20230119115733564.pdf.jpg202219-Jan-2023Emerging immunotherapy for HCC : a guide for hepatologistsFoerster, Friedrich; Gairing, Simon Johannes; Ilyas, Sumera Irie; Galle, Peter R.
elevated_serum_levels_of_meth-20220815115004627.pdf.jpg202115-Aug-2022Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosisMichel, Maurice; Hess, Cornelius; Kaps, Leonard; Kremer, Wolfgang M.; Hilscher, Max; Galle, Peter R.; Moehler, Markus; Schattenberg, Jörn M.; Wörns, Marcus-Alexander; Labenz, Christian; Nagel, Michael
significant_liver_fibrosis_is-20221121132447370.pdf.jpg202230-Jan-2023Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIVMichel, Maurice; Wahl, Alisha; Anders, Malena; Alqahtani, Saleh A.; Kremer, Wolfgang M.; Galle, Peter R.; Labenz, Christian; Grimm, Daniel; Sprinzl, Martin; Schattenberg, Jörn M.
ramucirumab_in_patients_with_-20220902173054571.pdf.jpg20217-Sep-2022Ramucirumab in patients with previously treated advanced hepatocellular carcinoma : impact of liver disease aetiologyGalle, Peter R.; Kudo, Masatoshi; Llovet, Josep M.; Finn, Richard S.; Karwal, Mark; Pezet, Denis; Kim, Tae-You; Yang, Tsai-Sheng; Lonardi, Sara; Tomasek, Jiri; Phelip, Jean-Marc; Touchefeu, Yann; Koh, Su-Jin; Stirnimann, Guido; Liang, Kun; Ogburn, Kenyon D.; Wang, Chunxiao; Abada, Paolo; Widau, Ryan C.; Zhu, Andrew X.
evaluation_of_a_laboratorybas-20220822134023960.pdf.jpg202123-Aug-2022Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admissionHäuser, Friederike; Sprinzl, Martin F.; Dreis, Kim J.; Renzaho, Angelique; Youhanen, Simon; Kremer, Wolfgang M.; Podlech, Jürgen; Galle, Peter R.; Lackner, Karl J.; Rossmann, Heidi; Lemmermann, Niels A.
burden_of_depression_and_anxi-20220822122501994.pdf.jpg202223-Aug-2022Burden of depression and anxiety disorders per disease codes in patients with lymphoma in GermanyTilch, Marie-Kristin; Galle, Peter R.; Schattenberg, Jörn M.; Kostev, Karel; Labenz, Christian
review_article__posttipss_hep-20230123094120726.pdf.jpg202223-Jan-2023Review article: post-TIPSS hepatic encephalopathy—current knowledge and future perspectivesGairing, Simon Johannes; Müller, Lukas; Kloeckner, Roman; Galle, Peter R.; Labenz, Christian
kaps_leonard-treatment_of_c-20210104145006284.pdf.jpg202020-Jan-2021Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection : a case reportKaps, Leonard; Labenz, Christian; Grimm, Daniel; Schwarting, Andreas; Galle, Peter R.; Schreiner, Oliver
mähringer-kunz_aline-predicting_sur-20210826101204684.pdf.jpg202026-Aug-2021Predicting survival after transarterial chemoembolization for hepatocellular carcinoma using a neural network : a pilot studyMähringer-Kunz, Aline; Wagner, Franziska; Hahn, Felix; Weinmann, Arndt; Brodehl, Sebastian; Schotten, Sebastian; Hinrichs, Jan B.; Düber, Christoph; Galle, Peter R.; Pinto dos Santos, Daniel; Kloeckner, Roman